https://regulatorynews.com/cardinal-health-presource-bd-alaris-early-alert Regulatory News en 2026-10-23T05:51:08-04:00 FDA Flags Recalled Infusion Sets in Cardinal Kits https://regulatorynews.com/fda-prescription-drug-software-guidance-final Regulatory News en 2026-10-23T05:51:08-04:00 FDA Finalizes Guidance on Drug Companion Apps https://regulatorynews.com/gsk-hibsago-bepirovirsen-hepatitis-b-approval Regulatory News en 2026-10-23T05:51:08-04:00 FDA Approves GSK's Hibsago for Chronic Hepatitis B https://regulatorynews.com/nouscom-series-d-nous-209-lynch-syndrome Regulatory News en 2026-10-22T10:03:48-04:00 Nouscom Raises $135M for Cancer-Prevention Vaccine https://regulatorynews.com/sab-biotherapeutics-sab-142-fast-track-t1d Regulatory News en 2026-10-22T10:03:48-04:00 SAB Bio Wins FDA Fast Track for Diabetes Drug https://regulatorynews.com/solventum-restrata-vac-therapy-510k-clearance Regulatory News en 2026-10-22T10:03:48-04:00 Solventum Clears FDA to Pair Two Wound Therapies https://regulatorynews.com/uk-ce-marking-indefinite-recognition Regulatory News en 2026-10-22T06:00:33-04:00 UK Confirms Indefinite Recognition of CE-Marked Devices https://regulatorynews.com/jemperli-dostarlimab-rectal-cancer-practice-impact Regulatory News en 2026-10-21T10:51:44-04:00 FDA Approves First Immunotherapy for Rectal Cancer https://regulatorynews.com/tumorsight-risk-ai-breast-cancer-recurrence-practice-impact Regulatory News en 2026-10-21T10:51:44-04:00 FDA Clears AI Tool to Score Breast Cancer Recurrence https://regulatorynews.com/cytokinetics-myqorzo-health-canada-approval Regulatory News en 2026-10-21T09:43:16-04:00 Cytokinetics Expands MYQORZO Access to Canada https://regulatorynews.com/estuary-biotherapeutics-series-a-financing Regulatory News en 2026-10-21T09:43:16-04:00 Estuary Launches With $103M for Kidney Gene Therapy https://regulatorynews.com/gore-viabahn-vbx-fevar-bevar-approval Regulatory News en 2026-10-21T09:43:16-04:00 Gore Wins FDA Nod for First On-Label Bridging Stent